February 7, 2019 (CAMBRIDGE, MA) – The Massachusetts Biotechnology Council (MassBio) today announced that Morgan Stanley is a premier sponsor of its 2019 Annual Meeting, which is now the State of Possible Conference and Celebration. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences and will include a celebration at the Museum of Science.
“We’re taking our Annual Meeting to a whole new level this year, rebranding it as the State of Possible Conference to celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago,” said Robert K. Coughlin, President and CEO of MassBio. “We’re honored to have Morgan Stanley’s support, which is testament to the critical role MassBio plays in supporting the life sciences ecosystem in Massachusetts.”
Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. The conference will take place at the Royal Sonesta in Cambridge on March 27th and 28th, and all attendees are encouraged to join State of Possible Celebration evening event on the 27th at the Museum of Science.
“Morgan Stanley understands the unique role investment firms have in fueling innovation and we’ve long recognized Massachusetts’s leadership in the life sciences industry globally,” said Joseph Malarney, Morgan Stanley Managing Director, Boston Complex Manager. “We’re thrilled to sponsor what is now the most influential biotech conference on the East Coast and we wholeheartedly support MassBio and its efforts to ensure Massachusetts remains the #1 life sciences cluster in the world.”
About Morgan Stanley
Morgan Stanley (NYSE: MS) is a leading global financial services firm providing investment banking, securities, wealth management and investment management services. With offices in more than 41 countries, the Firm's employees serve clients worldwide including corporations, governments, institutions and individuals. For more information about Morgan Stanley, please visit www.morganstanley.com.
MassBio is a not-for-profit organization founded in 1985 that represents and provides services and support for the Massachusetts life sciences industry. MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1,100+ biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy and promote education, while providing member programs, events, industry information, and services. Learn more at www.massbio.org.